Latest Updates on Pfizer Biotech Vaccine Trial |COVID-19 Vaccine|

Pfizer Biotech Vaccine Trial – Winter season is the season of viruses in North America. Before 2019, the United States was only recording positive cases of influenza, and the whole situation changed after the first detection of COVID-19 in Wuhan, China.

Health experts around the world are doing everything in their hands to save humanity from these two severe respiratory diseases, which are known to be the cause of millions of deaths around the world in the last two years.

Till now, the Centers for Disease Control and Prevention has been recommending every American get vaccinated with the vaccine of COVID-19 and flu vaccines for flu. Vaccine for viruses is one of the best ways to protect oneself from the infection of these viruses.

Now, the most popular duo of COVID vaccines in the world, Pfizer and BioNTech, have launched the first phase of the trial of a vaccine containing both COVID-19 and flu.

Pfizer BioNTech Vaccine Trial #1

Last week, Pfizer announced in a press release mentioning that they have initiated a phase one study of a single-dose vaccine containing influenza and COVID vaccine.

The company further mentioned that they have already initiated the phase one trial in the United States, and there are 180 participants between the age of 18 to 64. The first dose of the vaccine has already been administered, and the follow-up doses are going to be administered in the next six months.

The co-founder of biotech mentioned in a press statement that by combining both indications in one vaccine approach, we aim to provide individuals with an effective way to receive immunization against the most severe respiratory diseases.

The phase one trial is going to focus on the safety, immunity response, and optimal dose levels of the new Pfizer Biotech vaccine. The success of this vaccine can be a huge step forward in the sustainability of COVID vaccines as it can be easily combined in a single shot so that people won’t have to get themselves vaccinated with different vaccines.

Senior vice president and chief scientific officer of vaccine research and development for Pfizer called the new vaccine an exciting step in our ongoing journey to completely transform the prevention of infectious diseases around the world.

Representatives of both companies were very happy with the huge step, and we might hear more news in the upcoming weeks.

Is it Necessary to Combine Two Vaccines?

As you might already be aware, the Centers for Disease Control and Prevention has been suggesting Americans get themselves vaccinated with both vaccines for better protection during the winter season.

Even if you take a look at the data, people were much more excited to get themself vaccinated when the COVID vaccine was first launched. The interest in these vaccines has been fading away for the past few months, and the latest step of combining both vaccines can be a huge step forward.

One of the biggest benefits of combining these two vaccines can be the number of vaccinated people. Most of us are much more comfortable getting ourselves vaccinated with the flu shots each year, and combining the COVID vaccine with the flu vaccine can be a huge step forward in vaccinating most people in the country.

Since the very first day of the launch of COVID vaccines, health experts around the nation are struggling to keep the effectiveness of that scene up to the mark and provide better protection against several variants of the virus.

The combination of both vaccines will help the CDC to vaccinate people with the updated vaccines for better protection. If COVID vaccines are going to become annual doses like flu shots, then we require the new Pfizer Biotech vaccine to work perfectly.

Are there any other Projects Similar to the Pfizer Biotech Vaccine Trial?

The short answer is yes. Several other experiments are going on COVID vaccines, and one of the biggest competitors of Pfizer, Moderna, also announced their plans to work on a combo shot in the upcoming weeks.

Moderna announced in a recent press release that they are expecting to start the clinical trial of a single-dose vaccine that is going to be a combination of the COVID booster vaccine and flu booster by the end of the year.

The company is hoping to deliver the vaccine by the fall of 2023 so that Americans can get their hands on the combination shot for better protection against both viruses at the same time.

The Chief executive officer of Moderna also mentioned in a press statement on 9th September that Moderna believes this is a very large opportunity that is ahead of the world. Similar to Pfizer, Moderna is also very hopeful and positive when it comes to combining both vaccines.

One of the best parts about combining both vaccines is that the government won’t have to request everyone, again and again, to get themselves vaccinated with multiple vaccines every year. Till now, most governments around the world have established that COVID is going to be in our society forever, and it is going to become a normal condition.

Similar to Moderna, Novavax also enrolled people in phase one and two studies to evaluate the safety, tolerance, and immune response of a combination vaccine. Phase two trials are going to begin in December 2022, and they are also very hopeful for a positive outcome.

What do the Health Experts say about the New Pfizer Biotech Vaccine Trial?

Before we move ahead, let’s take a look at the reaction of several health experts around the nation on the New Pfizer Biotech vaccine trial.

The brand new Pfizer Biotech vaccine trial offers a vaccine against COVID-19, and the flu infection can be a game changer in the effort to protect Americans from the effect of both viruses at the same time, as per the Long Island infectious disease expert.

Even though the company has already mentioned that they are going to focus on the safety, effectiveness, and tolerability of the combination shot in the trial, health experts are much more hopeful.

The only problem with this new vaccine trial is the time frame. These companies will take around 6 to 12 months to complete the trial and come up with something conclusive.

The best part about the trial is that it is taking place within the United States, so we can rely on these results without any worries. 

Doctor Madad, resident and an infectious disease epidemiologist at Harvard university’s Belfer Center for science and international affairs, mentioned in a press statement that both viruses are distinct and can cause severe infection as well as strain healthcare systems.

She further added in her statement that having a one-shot approach is not just going to increase the vaccine coverage, but it can also prevent several outbreaks of both viruses during the winter season.

Most health experts around the nation are very hopeful and positive about the new approaches. The major reason behind their positive approach is the struggle of the Centers for Disease control and prevention. 

The CDC has been struggling to vaccinate as many Americans as possible, And the combination of both vaccines can provide immunity to the CDC.

Even if you take a look at the debates on several social media platforms and media houses, you will see that people are very frustrated with the repetitive vaccines and their inefficiency. Nowadays, people do not want to get themselves vaccinated with something that is not going to work, and the combination of both vaccines can solve that problem also.

What about the Safety of the Vaccine?

People are skeptical about the use of COVID vaccines in the United States as the whole incident of the Johnson and Johnson COVID vaccine hit the trust of Americans in COVID vaccines.

The Food and Drug Administration of the United States limited the use of the Johnson and Johnson COVID vaccine, which has been causing doubt in the minds of the general public.

Till the vaccine is approved by the FDA, it will be foolish to make any comments on the safety of the Pfizer Biotech combined vaccine. We will also advise you to wait till the company comes up with its full launch and the approval of the FDA. Bye

The company will submit documents including the safety of their vaccine in front of the FDA, and then we will comment on the same.